- Home
- /Epstein Barr virus capsid Ab.IgG
Epstein Barr virus capsid Ab.IgG
Detects EBV antibodies in cerebrospinal fluid, indicating central nervous system infection.
Why This Biomarker Matters
EBV antibodies in spinal fluid indicate serious brain or spinal cord infection. This finding requires urgent specialist evaluation and may influence treatment decisions for CNS complications.
Overview
This test detects Epstein-Barr virus (EBV) antibodies in cerebrospinal fluid (CSF), the fluid surrounding the brain and spinal cord. EBV antibodies in CSF indicate the virus has infected the central nervous system, suggesting conditions like meningitis, encephalitis, or post-viral neurological complications. This test is performed when patients have neurological symptoms and suspected EBV involvement. A positive result in CSF is more significant than in blood and indicates serious CNS infection requiring urgent evaluation.
Technical Information (LOINC Codes)
Standardized laboratory codes for this biomarker
30339-6Primary24114-140750-25158-17885-75157-311009-820490-947064-147432-016827-858760-016826-022291-993713-6Available Lab Tests
Order tests that measure this biomarker